Despite this, it remains uncertain whether there are variances in the manifestation of FSCN1 among various histological types of liver cancer, such as HCC and ICC, as well as its correlation with different clinicopathological characteristics of patients. This evidence concerns the gene FSCN1 and intrahepatic cholangiocarcinoma.